We are live on ! Find out more
TCM

Trybe Capital Management Portfolio holdings

AUM $1.09B
1-Year Est. Return 249.75%
This Fund
S&P 500
This Quarter Est. Return
+2.03%
1 Year Est. Return
+249.75%
3 Year Est. Return
+680.91%
5 Year Est. Return
+833.26%
10 Year Est. Return
AUM
$176M
AUM Growth
+$11.7M
Cap. Flow
+$9.31M
Cap. Flow %
5.3%
Top 10 Hldgs %
91.28%
Holding
14
New
2
Increased
Reduced
Closed
2

Top Buys

Rank Stock Value
1
DNA icon
Ginkgo Bioworks
DNA
+$14.7M
2
MRVL icon
Marvell Technology
MRVL
+$6.56M

Sector Composition

Rank Sector Weight
1 Technology 58.4%
2 Communication Services 16.22%
3 Consumer Discretionary 8.95%
4 Financials 8.45%
5 Healthcare 7.97%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
NVDA icon
1
NVIDIA
NVDA
$5.25T
$24.6M 13.99%
1,185,600
GOOGL icon
2
Alphabet (Google) Class A
GOOGL
$4.17T
$19.8M 11.26%
147,920
MSFT icon
3
Microsoft
MSFT
$3.57T
$17.7M 10.11%
62,952
NOW icon
4
ServiceNow
NOW
$134B
$17.1M 9.75%
137,610
AMZN icon
5
Amazon
AMZN
$2.81T
$15.7M 8.95%
95,740
PYPL icon
6
PayPal
PYPL
$53.3B
$14.8M 8.45%
57,032
DNA icon
7
Ginkgo Bioworks
DNA
$469M
$14M 7.97%
+30,200
New +$14.7M
CRM icon
8
Salesforce
CRM
$168B
$12.6M 7.16%
46,384
AAPL icon
9
Apple
AAPL
$4.54T
$12.6M 7.16%
88,837
PLTR icon
10
Palantir
PLTR
$418B
$11.4M 6.47%
472,953
MTCH icon
11
Match Group
MTCH
$9.26B
$8.72M 4.96%
55,523
MRVL icon
12
Marvell Technology
MRVL
$225B
$6.6M 3.76%
+109,407
New +$6.56M
ARKG icon
13
ARK Genomic Revolution ETF
ARKG
$1.87B
-64,381
Closed -$5.96M
SRNG
14
DELISTED
Soaring Eagle Acquisition Corp. Class A Ordinary Share
SRNG
-601,698
Closed -$5.99M

Similar funds

Trybe Capital Management's Q3 2021 Portfolio in Review

As of Q3 2021, Trybe Capital Management held 14 positions worth $176M, up 7.1% from $164M the previous quarter. Its ten largest holdings account for 91% of the portfolio.

Trybe Capital Management deployed $9.31M of net new capital in Q3 2021, opening 2 new positions. Its largest new stake was Ginkgo Bioworks: 30,200 shares worth $14M.

By sector, the portfolio is most concentrated in Technology at 58% of assets, up from 56% a quarter earlier, followed by Communication Services and Consumer Discretionary.

On the sell side, the most notable exit was Soaring Eagle Acquisition Corp. Class A Ordinary Share, an estimated $5.99M sold.

  • Trybe Capital Management's largest Q3 2021 buy was Ginkgo Bioworks: 30,200 shares worth $14M.
  • Trybe Capital Management fully exited Soaring Eagle Acquisition Corp. Class A Ordinary Share in Q3 2021, selling an estimated $5.99M.
  • Trybe Capital Management's ten largest holdings make up 91% of its $176M portfolio in Q3 2021.
  • Trybe Capital Management opened 2 new positions and closed 2 in Q3 2021.
  • Trybe Capital Management's portfolio value rose 7.1% quarter-over-quarter to $176M.

Based on Trybe Capital Management's 13F filing for Q3 2021, filed 15 Nov 2021.